Amino Acid CSF - Quantitative

The Amino Acid CSF - Quantitative test measures the concentrations of multiple amino acids in cerebrospinal fluid. Cerebrospinal fluid, commonly called CSF, surrounds and protects the brain and spinal cord. Its amino acid composition can provide important information about metabolism within the central nervous system and may help specialists investigate selected inherited metabolic, neurological and developmental disorders.

Amino acids are the building blocks used to form proteins, but they also participate in energy production, neurotransmission and numerous biochemical pathways. Abnormally high or low concentrations in CSF may occur when a transport protein or metabolic enzyme does not function correctly. Because several disorders produce overlapping symptoms, quantitative analysis is generally interpreted with plasma amino acids, urine organic acids, genetic testing and other clinical investigations.

Benefits of the Test

• Measures multiple amino acids in cerebrospinal fluid.
• Supports investigation of rare inherited amino acid metabolism disorders.
• Helps evaluate selected neurological and developmental abnormalities.
• May support assessment for nonketotic hyperglycinemia and serine deficiency disorders.
• Allows comparison of CSF and plasma amino acid concentrations when collected appropriately.
• Guides confirmatory biochemical, enzymatic or genetic investigations.

Why Doctors Recommend This Test

A neurologist, paediatrician, clinical geneticist or metabolic specialist may recommend quantitative CSF amino acid testing for patients with unexplained seizures, developmental delay, abnormal muscle tone, reduced alertness, movement abnormalities, breathing problems, neurological regression or an unusual response to treatment. It is usually requested when the clinical pattern or previous laboratory findings suggest a rare metabolic condition affecting the brain.

One important use is the assessment of nonketotic hyperglycinemia, also known as glycine encephalopathy. This inherited disorder can cause excessive glycine accumulation, particularly within the central nervous system. Doctors may compare CSF glycine with a plasma glycine sample collected at approximately the same time and calculate a CSF-to-plasma glycine ratio. The ratio and individual concentrations must be interpreted carefully because contamination of CSF with blood can affect the result.

The test may also contribute to investigating disorders involving serine synthesis or transport, where CSF serine can be abnormally low. Other amino acid patterns may provide clues to additional metabolic, transport or neurological abnormalities. A single altered amino acid is rarely sufficient for diagnosis, and confirmatory testing is usually necessary.

Preparation Before Test

CSF is collected through a lumbar puncture performed by a trained medical professional in a hospital or suitable clinical setting. Patients or caregivers should follow the treating team's instructions regarding food, medicines, sedation and other preparation. Tell the doctor about anticoagulants, bleeding disorders, infection near the proposed puncture site and all current medicines.

The laboratory should be contacted before collection to confirm the required volume, sterile container, processing, freezing and transportation instructions. When a CSF-to-plasma comparison is needed, the blood sample should be collected at the time specified by the metabolic specialist. Samples must be labelled accurately. Blood-contaminated or improperly stored CSF may produce misleading results.

Normal Reporting Time

Quantitative CSF amino acid analysis is a highly specialized metabolic test and generally requires several working days or longer. Reporting time depends on the analytical schedule, specimen transport, sample quality, number of amino acids measured and whether repeat or confirmatory analysis is needed. Focus Diagnostics will provide the applicable turnaround estimate before or during specimen submission.

Who Should Take This Test?

• Infants or children with unexplained seizures, lethargy or abnormal muscle tone.
• Patients with developmental delay or progressive neurological abnormalities.
• Individuals being evaluated for nonketotic hyperglycinemia.
• Patients with suspected serine deficiency or another amino acid metabolism disorder.
• People with abnormal plasma amino acid results requiring central nervous system evaluation.
• Patients specifically referred by a neurologist, geneticist or metabolic specialist.

Detailed Information

Quantitative analysis identifies and measures amino acids rather than merely reporting whether they are present. The laboratory compares each result with an age-appropriate and method-specific reference interval. Age is especially important because amino acid concentrations and clinical presentation can differ between newborns, children and adults.

CSF results should not be interpreted independently of the collection conditions. A traumatic lumbar puncture can introduce blood into the specimen, changing amino acid concentrations. Diet, medicines, seizures, illness and sample-handling delays may also influence certain measurements. A paired plasma amino acid sample can help specialists distinguish a systemic abnormality from one that is more prominent in the central nervous system.

If the pattern suggests a specific disorder, further evaluation may include plasma amino acids, urine organic acids, acylcarnitine profiling, ammonia, lactate, enzyme analysis and molecular genetic testing. In suspected nonketotic hyperglycinemia, genetic testing of genes associated with the glycine cleavage system may be considered. In suspected serine deficiency, targeted biochemical and genetic studies may be requested.

Treatment depends entirely on the confirmed diagnosis and may include dietary measures, vitamin or cofactor therapy, medicines that modify amino acid concentrations or neurotransmitter activity, seizure management and developmental support. These treatments require specialist supervision. The CSF amino acid result should always be reviewed by a clinician experienced in inherited metabolic or neurological disorders.